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ABSTRACT
Whey is a polluting by-product of cheese processing. 
However, it has valuable nutritional properties that can 
be exploited for diverse applications. Research has shown 
how whey proteins enzymatic hydrolysis releases bioactive 
peptides. In the present study, the whey protein concentrate 
(WCP) hydrolysis was performed using purified Sporisorium 
reilianum aspartyl protease (Eap1), with commercial enzymes 
chymotrypsin (C) and trypsin (T), as well as different enzy-
matic combinations in order to determine which enzyme or 
combination allowed for the release of peptides presenting 
the highest antioxidant and antihypertensive activity levels. 
Our results indicated that hydrolysis with Eap1 releases the 
best-performing peptides (1467.30 mM AAEAA/100g WCP; 
835.20 mM FeSO4 /100g WCP and 83.36 % ACE inhibition) 
in comparison with individual enzymes (Q: 1164.60 mM 
AAEAA/100g WCP; 305.35 mM FeSO4/100g WCP; 92.35 % ACE 
inhibition and T: 354.87 mM AAEAA/100g WCP; 205.82 mM 
FeSO4/100g WCP; 83.8 % ACE inhibition) and their combina-
tions (Eap1-C: 1050.23 mM AAEAA/100g WCP; 399.09 mM 
FeSO4/100g WCP; 85.58 % ACE inhibition, Eap1-T: 882.5 mM 
AAEAA/100g WCP; 220.63 mM FeSO4/100g WCP; 85.40 % ACE 
inhibition, C-T: 994.67 mM AAEAA/100g WCP; 310.43 mM 
FeSO4/100g WCP; 61.27 % ACE inhibition and C-Eap1-T: 93.23 
mM AAEAA/100g WCP; 23.3 mM FeSO4/100g WCP; 38.35 % 
ACE inhibition).
Keywords: antioxidant peptides; antihypertensive peptides; 
protein concentrate from bovine whey; aspartyl protease of 
Sporisorium reilianum; commercial enzymes.
RESUMEN
El lactosuero es considerado un subproducto conta-
minante de la industria quesera, sin embargo, cuenta con 
importantes propiedades nutrimentales que pueden ser 
aprovechadas. Estudios indican que la hidrólisis enzimática 
de sus proteínas permite liberar péptidos bioactivos. En este 
estudio, se realizó la hidrólisis del concentrado proteico del 
lactosuero (WCP) por acción de la aspartil proteasa purificada 
de Sporisorium reilianum (Eap1), con las enzimas comerciales 
quimotripsina (C), tripsina (T) y de su combinación enzimáti-
ca, con la finalidad de determinar que enzima permite liberar 
péptidos con mejor actividad antioxidante y antihipertensi-
va. Los resultados indicaron que la Eap1 libera péptidos con 
mejor actividad (1467.30 mM AAEAA/100g WCP; 835.20 mM 
FeSO4/100g WCP; 83.36 % inhibición ACE) en comparación 
con las enzimas individuales (Q: 1164.60 mM AAEAA/100g 
WCP; 305.35 mM FeSO4/100g WCP; 92.35 % inhibición ACE 
y T: 354.87 mM AAEAA/100g WCP; 205.82 mM FeSO4/100g 
WCP; 83.8 % inhibición ACE) y sus combinaciones (Eap1-C: 
1050.23 mM AAEAA/100g WCP; 399.09 mM FeSO4/100g WCP; 
85.58 % inhibición ACE, Eap1-T: 882.5 mM AAEAA/100g WCP; 
220.63 mM FeSO4/100g WCP; 85.40 % inhibición ACE, C-T: 
994.67 mM AAEAA/100g WCP; 310.43 mM FeSO4/100g WCP; 
61.27 % inhibición ACE y C-Eap1-T: 93.23 mM AAEAA/100g 
WCP; 23.3 mM FeSO4/100g WCP; 38.35 % inhibición ACE).
Palabras clave: péptidos antioxidantes, péptidos antihi-
pertensivos, concentrado proteico del suero lácteo bovino, 
aspartil proteasa de Sporisorium reilianum, enzimas comer-
ciales.
INTRODUCTION
Whey represents a rich and balanced protein source 
of amino acids, which allow for a wide range of functional 
properties. Specifically, whey proteins make up to 20 % of 
cow milk protein content. Besides their nutritional value (due 
to their high biological value indexes), in many cases, they 
also exert biological and physiological effects on the organ-
ism (Baró et al., 2001). The presence of leucine, isoleucine, 
tyrosine, methionine, proline, and valine in the structure of 
α-Lactalbumin (α-La), β-Lactoglobulin (β-Lg), immunoglob-
ulins (Ig), albumin (BSA), lactoferrin (LF), and lactoperoxidase 
(LP), has given rise to possible applications for the hydrolysis 
of these proteins to obtain peptides with different biologi-
cal properties (Muro-Urista et al., 2011; Tovar-Jiménez et 
al., 2017). Biological properties are partially attributed to 
peptides encoded in proteins, which are released after pro-
teolytic digestion (Clare and Swaisgood, 2000; Gobbetti et al., 
2002). Whey peptides have multifunctional properties such 
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as antioxidant, antihypertensive, opioid, and immunomodu-
latory, among others, and these bioactive peptides are used 
in products such as infant foods, energy drinks, and hypoal-
lergenic foods to offer added value and improve consumer 
health (Mensink, 2006; Pfeuffer and Schrezenmeir, 2006). 
The release of bioactive peptides from whey proteins 
has been studied over the past decade, but many of the stud-
ies have used only digestive enzymes chymotrypsin (C) and 
trypsin (T) (Lagrange and Clark, 2018; Maoa et al., 2018; Ka-
mal et al., 2018; Atacan et al., 2016; Rocha et al., 2011; Bayram 
et al., 2008). Studies on the hydrolysis of these proteins have 
not yet been carried out using the enzyme Eap1, produced by 
the phytopathogen S. reilianum, which has 41 kDa molecular 
weight and it is an aspartyl protease stable at a wide range of 
temperatures (4 to 45 ºC) and pH (3 to 5) values, but 45 ºC and 
pH 3 are optimal points (Mandujano-González et al., 2013) 
and shows high proteolytic capacity, because it allows us to 
obtain hydrolysates with antimicrobial activity higher that 
that generated by C and T, and it was also shown that Eap1 
hydrolysates were the only ones that inhibited growth of the 
yeast C. albicans (Tovar-Jiménez et al., 2017). This suggests it 
could be used like an important biotechnological alternative 
in the food industry, in the improvement of bio‐functional 
properties or modulating the techno‐functional properties 
of foods due to its high stability at temperature and pH. Since 
in recent years much of the scientific interest has focused on 
finding functional foods or ingredients that contribute to the 
treatment and prevention of degenerative diseases, the rise 
of bioactive peptides, as a health issue, still remains open, 
since peptides obtained and their activity depend on the 
source of the protein and enzymes used.
Likewise, the enzymatic hydrolysis has not been car-
ried out with the combination of Eap1 with enzymes C and 
T. Thus, the purpose of the present study was to determine 
whether the action of Eap1-released peptides presents 
better biological activity than those released by commer-
cial enzymes C and T; in addition, enzymatic cocktails were 
prepared to determine whether the enzymatic activities of 
these three enzymes are summative and whether they result 
in higher levels of antioxidant and antihypertensive activity 
in the obtained peptides.
MATERIALS AND METHODS
Ten liters of bovine cheese whey from a cheese in-
dustry (México country) were used to obtain whey protein 
concentrate. Samples of 500 mL (511.5 g) of whey were 
stored at 5 °C before use. Bovine whey proteins were precip-
itated with (NH4)2SO4, then filtered using nitrocellulose filter 
paper (Millipore, pore size: 0.45 μm, and dialyzed using a 
membrane (Thermo Scientific, pore size: KDa). Dialysis was 
performed until samples reached conductivity <1 μS cm-1 
(Tovar-Jiménez et al., 2012).
Microorganism
The S. reilianum strain was donated by Dr. Santos 
Gerardo Leyva, of the Universidad Autónoma Chapingo (Mé-
xico). It was grown by periodic cultures in YPD-Agar medium 
(yeast extract 1%, bacto™ peptone 2%, glucose 2%, and agar 
1.5%), incubated at 28 °C for 3 days.
Enzymatic hydrolysis
Purification of the Eap1enzyme, was performed as 
indicated by Mandujano-González et al. (2013), using anion 
exchange chromatography with a Bio-Scale Mini UNO sphere 
Q Cartridge column, coupled to an FPLC system (Bio-Rad). 
A lineal NaCl gradient was applied (J. T. Baker®), 1 M in Tris 
(Sigma®), 20 mM at pH 8, and the eluted fraction was taken 
at a NaCl concentration (J. T. Baker®) between 0.45 and 0.55 
mol/L, and commercial enzymes of animal origin, trypsin (T) 
from bovine pancreas (Sigma®) and chymotrypsin (C) from 
bovine pancreas (Sigma®) were used to perform hydrolysis 
at the enzymatic activity levels of 1.37, 3.13, and 3.7 mUA/
mL; hydrolysis was also carried out using four enzyme com-
binations (Eap1-C, Eap1-T, CT, and C-Eap1-T) at an enzymatic 
activity level of 1.37 mUA/mL. 
Hydrolysis kinetics was carried out from 0 to 120 
min at 37 °C and optimum pH for each individual enzymes 
and pH 6. The substrate was adjusted to a concentration of 
179.4 μg WCP protein. The non-hydrolyzed proteins were 
precipitated with 500 μL of 10% trichloroacetic acid. The 
reaction mixture was centrifuged at  g for 5 min. Finally, the 
supernatant was used to quantify the peptides released after 
hydrolysis following the micro-Lowry method as reported 
by Figueroa-Hernández et al. (2012). Calculation of the 
peptides released was done on the basis of curve pattern of 
tyrosine at a concentration of 0-23 μg/mL. All determinations 
were performed in sextuplicate with the following controls: 
WCP+TCA+Enzyme, WCP+Sterile distilled water+Enzyme, 
and Sterile distilled water+TCA+Enzyme. Finally, the biologi-
cal activity of the hydrolysis product was determined. 
Determination of biological activity of released peptides
The antioxidant and antihypertensive activities of 
the peptides released after the enzymatic hydrolysis were 
analyzed.
Determination of antioxidant activity
A solution of 7 μM ABTS (AMRESCO ultra-pure grade) 
was mixed with 4.9 μM ammonium persulfate (Sigma Aldrich 
brand) at a 1:1 ratio. The radical ABTS·+ was formed after 16 
h. ABTS solution was diluted until reaching absorbance 
between 0.7 and 754 nm, which was achieved by mixing 
approximately 40 μL of the ABTS·+ solution with 960 μL of ab-
solute ethanol (v/v). Twenty μL of the sample (released pep-
tides) were added to 980 μL of the dilution, and the change 
in absorbance was measured 7 min after the reaction. The 
percentage inhibition of ABTS·+ radical was calculated using 
the pattern curve prepared with ascorbic acid [2mM] (MP 
Biomedicals), in concentrations from 0 to 0.8 mM. Data are 
reported as mM of antioxidant activity equivalent to ascorbic 
acid per 100 g WCP (mM AAEAA/100 g WCP) (Tovar-Jiménez 
et al., 2012; Mendoza-Jiménez et al., 2018).
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Ferric Reducing Antioxidant Power (FRAP) Assay
The FRAP assay was performed according to the 
method described by Luo et al. (2012). In the assay kit with 
FRAP method, stock solutions include detective buffer, 
2,4,6-tripyridyl-s-triazine (TPTZ) solution, and TPTZ solution. 
The working solution was prepared before use by mixing 
TPTZ dilution, detective buffer, and TPTZ solution at a ratio 
of 10:1:1 (v/v/v), respectively, then the working solution was 
incubated at 37 °C. Fourteen µL of hydrolyzed sample (0.1 mg 
peptides/mL in PBS) were added to the TPTZ solution (504 
µL) in a eppendorf tube. After incubation for 30 min at 25 °C, 
the absorbance of the reaction mixture was measured at 593 
nm with a spectrophotometer. The ferric reducing activity 
was calculated using the FeSO4 solution (200 mM–1200 mM) 
calibration curve and was converted to the Fe2+ antioxidant 
capacity value, which was expressed as FeSO4 mM/100 g WCP. 
Determination of antihypertensive activity
The present study used a method described by Na-
kamura et al. (1995). Eighty μL of water or 80 μL of the sample 
adjusted to a pH of 8.3, were added to 200 μL of the substrate 
solution, consisting of Hipuryl-Histidyl-Leucine at a concen-
tration of 5 mM, dissolved in 0.1 M sodium borate buffer and 
0.3 M NaCl, at pH 8.3. Mixtures were pre-incubated at 37 °C. 
Twenty μL of ACE (0.1 U/mL, Sigma-Aldrich) were added to 
initiate the reaction, and the mixture was incubated at 37 
°C for 30 min, and then decreasing pH with 250 μL of 1 M 
HCl to inactivate the enzyme. The hippuric acid formed in 
the reaction was extracted by vigorous stirring for 10 s after 
adding 1 mL of ethyl acetate. It was then centrifuged at 4000 
g for 10 min at 25 °C, and 500 μL of the organic phase were 
withdrawn. Ethyl acetate was removed by heating at 95 °C 
for 10 min. The hippuric acid residue was re-dissolved in 1 mL 
distilled water, and after shaking, the absorbance at 228 nm 
was measured by the spectrophotometer. A reaction target 
was prepared by adding HCl prior to the addition of ACE and 
Captopril was used as the positive control in this study. The 
activity of each sample was determined in triplicate, and the 
results were expressed as percentages of ACE inhibition.
Statistical analysis
For data analysis, the multifactorial analysis of varian-
ce methodology was used to determine the individual and 
joint effects of the factors (enzymatic activity, hydrolysis time 
and enzyme) on the responses variables (antioxidant and 
antihypertensive peptides released). Later, the LSD contrast 
test (minimum significant difference) was performed at a 
95% confidence level. The Statistica 7.0 for Windows statisti-
cal program was used. Graphs are expressed in means ± LSD 
interval.
RESULTS AND DISCUSSION
Kinetics of WCP hydrolysis with Eap1, C and T enzymes
Peptides released during hydrolysis of whey proteins 
depends on the proteolytic activity and time (Figure 1); that 
is, larger quantities of these compounds are released with 
 
Figure 1: Peptides released from the whey protein concentrate by enzymatic hydrolysis with enzymes A: Eap1, B: chymotrypsin and C: trypsin at different 
units of enzyme activity (▲1.37 mAU/mL,  3.13 mAU/mL, ◆ 3.71 mAU/mL) and hydrolysis time.
Figura 1: Péptidos liberados del concentrado proteico del suero lácteo por hidrólisis enzimática empleando las enzimas A: Eap1, B: Quimotripsina y C: 
Tripsina a diferentes unidades de actividad enzimática (▲1.37 mUA/mL,  3.13 mUA/mL, ◆ 3.71 mUA/mL) y tiempo de hidrólisis.
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Eap1 and C to 3.71 mUA/mL without statistically significant 
differences (p >0.05; R2adjusted: 0.9056) with the T enzyme to 
1.37 mUA/mL to 120 min hydrolysis time. The statistical anal-
ysis showed that there are significant differences (p <0.05; 
R2adjusted: 0.9902) between the units of enzymatic activity and 
the hydrolysis times evaluated. More extensive hydrolysis of 
WPC with these enzymes may be attributed to their broader 
specificities to cleave various peptide bonds. In this sense, 
the aspartyl protease Eap1 prefers to hydrolyze the adjacent 
carbon, where amino acids phenylalanine, proline, tyrosine, 
and leucine, while C enzyme hydrolyze the adjacent carbon 
of amino acids tyrosine, phenylalanine, and tryptophan, and 
T enzyme hydrolyze preferentially in the adjacent carbon of 
amino acids arginine and lysine. Likewise, the reaction time 
only determines the final degree of hydrolysis but the en-
zyme/substrate ratio directly influences the degree of hydro-
lysis and composition of the released peptides (Lagrange and 
Clark, 2018; Maoa et al., 2018; Kamal et al., 2018; Muro-Urista 
et al., 2011; Zakharova et al., 2009; Peng et al., 2009; Erdmann 
et al., 2008).
Determination of biological activity of released peptides
The antioxidant and antihypertensive activities of 
the peptides obtained from the hydrolysis were measured 
to determine which enzyme or combination resulted in the 
most substantial peptide-releasing activity. Our observations 
show a positive association between the release of bioactive 
peptides and enzyme activity units (Figure 2, 3 and 4).
Peptides with antioxidant activity released by the action 
of Eap1, and enzymes C and T
Figure 2 shows the antioxidant activity of peptides re-
leased at different times (0, 30, 60, 90, and 120 min). Eap1-re-
leased peptides present better antioxidant activity (1467.30 
± 23.86 mM AAEAA/100 g WCP) at an enzymatic activity of 
1.37 mUA/mL in comparison with enzymes C (1164.60 ± 31.25 
mM AAEAA/100 g WCP) and T (354.87 ± 7.16 mM AAEAA/100 
g WCP) at the different activity levels studied. Likewise, Fig-
ure 3 shows the ferric reducing capacity of peptides released 
at different hydrolysis time. At an activity of 1.37 mUA/mL, 
Eap1-released peptides showed better ferric reducing capac-
ity (835.20 ± 12 FeSO4 mM/100 g WCP) in comparison with 
enzymes C and T at the different activity levels studied. The 
statistical analysis showed significant differences (p <0.05; R2 
adjusted: 0.9864 and R
2 adjusted: 0.9824, respectively) between hy-
drolysis times and enzymatic activities among the different 
enzymes studied for both studies.
The results obtained in the present study may be 
due to the fact that Eap1 prefers to hydrolyze the adjacent 
carbon, where amino acids phenylalanine, proline, tyrosine, 
and leucine are found (Hedstrom, 2002), which results in 
the generation of peptides with antioxidant activity, since 
these peptides require having amino acids such as tyrosine, 
methionine, tryptophan, and histidine at its terminal carbon 
as indicated Erdmann et al. (2008). In this sense, The WCP 
used contained β-Lg and α-La that present 3.7 and 4 % of the 
amino acid tyrosine in their structures, respectively, which 
 
Figure 2: Antioxidant activity of peptides released from the whey protein concentrate by enzymatic hydrolysis with enzymes A: Eap1, B: chymotrypsin and C: 
trypsin at different units of enzyme activity (▲1.37 mAU/mL,  3.13 mAU/mL, ◆ 3.71 mAU/mL) and hydrolysis time.
Figura 2: Actividad antioxidante de los péptidos liberados del concentrado proteico del suero lácteo por hidrólisis enzimática empleando las enzimas A: Eap1, 
B: Quimotripsina y C: Tripsina a diferentes unidades de actividad enzimática (▲1.37 mUA/mL,  3.13 mUA/mL, ◆ 3.71 mUA/mL) y tiempo de hidrólisis.
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Figure 4: ACE inhibition percentage of peptides released from the whey protein concentrate by enzymatic hydrolysis with 
enzymes A: Eap1, B: chymotrypsin and C: trypsin at different units of enzyme activity (▲1.37 mAU/mL,  3.13 mAU/mL, ◆ 
3.71 mAU/mL) and hydrolysis time.
Figura 4: Actividad antihipertensiva de los péptidos liberados del concentrado proteico del suero lácteo por hidrólisis enzi-
mática empleando las enzimas A: Eap1, B: Quimotripsina y C: Tripsina a diferentes unidades de actividad enzimática (▲1.37 
mUA/mL,  3.13 mUA/mL, ◆ 3.71 mUA/mL) y tiempo de hidrólisis.
Figure 3: Ferric reducing activity of peptides released from the whey protein concentrate by enzymatic hydrolysis with 
enzymes A: Eap1, B: chymotrypsin and C: trypsin at different units of enzyme activity (▲1.37 mAU/mL,  3.13 mAU/mL, ◆ 
3.71 mAU/mL) and hydrolysis time.
Figura 3: Potencial reductor férrico de los péptidos liberados del concentrado proteíco del suero lácteo por medio de hi-
drólisis enzimática con las enzimas A: Eap1, B: quimotripsina y C: tripsina a diferentes unidades de actividad enzimática 
(▲1.37 mAU/mL,  3.13 mAU/mL, ◆ 3.71 mAU/mL) y tiempo de hidrólisis.
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can be released by the action of Eap1. The fact that peptides 
presenting lower activity were obtained from hydrolysis with 
C could be explained because, in this case, the enzyme pre-
fers to hydrolyze the adjacent carbon of amino acids tyrosine, 
phenylalanine, and tryptophan (Zakharova et al., 2009), and 
even in the presence of amino acid tryptophan the antioxi-
dant activity is lower than that obtained by Eap1, because the 
structures of β-Lg and α-La contain approximately 1 % of this 
amino acid, and this biological activity also depends on the 
amino acid sequence and the size of the released peptides 
(Peña-Ramos and Xiong, 2001; Erdmann et al., 2008; Peng et 
al., 2009; Muro-Urista et al., 2011). As for the T enzyme, the 
low activity of the peptides obtained can be attributed to the 
fact that β-Lg, BSA, Lf, and Ig are constituted by lysine and ar-
ginine (30 and 6 %, 59 and 23 %, 54 and 37 %, and 82 and 84 
%, respectively) (Muro-Urista et al., 2011), which may indicate 
a higher degree of hydrolysis because enzyme T hydrolyzes 
preferentially in the adjacent carbon of amino acids arginine 
and lysine (Zakharova et al., 2009) (Figure 1), and as reported 
by Peña-Ramos and Xiong (2001) and Peng et al. (2009) who 
indicate that the effect of the antioxidant activity depends 
on the composition of amino acids, the sequence, and the 
configuration of the peptides obtained. Moreover, results 
presented by Peña-Ramos and Xiong (2001) suggest that the 
degree of hydrolysis exerted by T on β-Lg is higher compared 
to the degree exerted by T on α-La, generating peptides with 
lower antioxidant activity. According to Bayram et al. (2008), 
antioxidant activity is inherent to β-Lg, BSA, and Lf.
Peptides with antihypertensive activity released by the 
action of Eap1, C and T.
Figure 4 shows antihypertensive activity (ACE inhibi-
tion percentage) and hydrolysis time. As can be observed, 
when WCP hydrolysis was carried out using the three enzymes, 
with different activity units, peptides with antihypertensive 
activity were released. Higher levels of biological activity and 
shorter reaction times were obtained in the present study in 
comparison with those reported by Hernández-Ledesma et 
al. (2006), who hydrolyzed β-Lg from sheep and goat whey 
using enzymes of animal origin (T and C) and reported that, 
after hydrolysis for 36 h with T, the peptides obtained from 
the β-Lg of ovine origin presented 74.6 % of ACE inhibition, 
and those obtained from β- Lg of caprine origin presented 
73.9 % inhibition after hydrolysis for 24 h. The same authors 
reported that, when the hydrolysis of β-Lg of ovine and 
caprine origin is carried out using C, 73.6 % and 64.9 % of 
ACE inhibition are obtained, respectively, after hydrolysis 
for 24 h, whereas the released peptides in the present study 
showed an activity of 83 % of ACE inhibition after hydrolysis 
for 90 min with Eap1 and T. The statistical analysis showed 
a significant difference (p <0.05, R2 adjusted: 0.97) between the 
time of hydrolysis, enzyme and enzymatic activity evaluated. 
These results can be due to the fact that β-Lg, BSA, 
Lf, and α-La constitute the WCP used, and this activity is 
inherent to these proteins (Maneva et al., 2003; Prioult et al., 
2004). Also, as reported in the literature, peptides that show 
ACE inhibitory activity possess hydrophobic residues, such 
as tryptophan, tyrosine, or phenylalanine, in at least one of 
the three C-terminal positions where they bind to the ACE 
active sites, blocking its activity (Aleixandre et al., 2008). It has 
also been reported that sequences of short chain peptides 
carrying proline residues, in combination or not with hydro-
phobic residues, inhibit ACE (Hartmann and Meisel, 2007; 
Murakami et al., 2004). Additionally, the inhibitory potency 
can be increased with the presence of positive charges of 
lysine and arginine in the C-terminal, because they represent 
30% of WCP (Muro-Urista et al., 2011; Hernández-Ledesma et 
al., 2008; Dziuba et al., 1999).
When analyzing the biological activity results obtained 
in connection with the three studied activities (1.37, 3.13, and 
3.71 mUA/mL) of the evaluated enzymes (Eap1, C, and T), it 
was decided to use the enzymatic activity of 1.37 mUA/mL, 
since it presented an acceptable level of biological activity 
and the process requires a lower amount of enzyme, which 
could result in lower costs for bioactive peptide production. 
In this regard, studying an enzymatic cocktail would make 
it possible to determine whether the enzymatic activities of 
these three enzymes are summative and their combination 
results in higher biological activity in comparison with pep-
tides obtained using individual enzymes.
Hydrolysis Kinetics of WCP with the enzymatic combina-
tion.
Four enzyme combinations, aspartyl protease-
chymotrypsin (Eap1-C), aspartyl protease-trypsin (Eap1-T), 
trypsin-chymotrypsin (TC), and aspartyl protease-chymo-
trypsin-trypsin (Eap1-CT), were evaluated to determine their 
ability to release bioactive peptides at different times (30, 
60, 90, and 120 min). Figure 5 show that peptides released 
during hydrolysis of whey proteins, depends on hydrolysis 
time and enzyme or enzyme combinations; likewise, that the 
larger quantities of these peptides are released with enzyme 
combinations, which suggests a higher degree of hydrolysis, 
however, biological activity peptides also depends on the 
composition of amino acids, the sequence, and the configu-
ration of the peptides obtained (Tovar-Jiménez et al., 2017). 
The statistical analysis showed significant differences (p 
<0.05; R2 adjusted: 0.9593) between hydrolysis times and enzy-
me used.
Antioxidant activity peptides released by enzymatic 
combination
Figure 6 shows antioxidant activity (mM AAEAA/100g 
WCP) with respect to hydrolysis time. As can be observed, 
enzyme Eap1 (1467.30 ± 23.86 mM AAEAA/100 g WCP) 
and combinations C-T (994.67 ± 14.55 mM AAEAA/100 g 
WCP) and Eap1-C (1050.23 ± 13.99 mM AAEAA/100 g WCP) 
released peptides with better antioxidant activity; with no 
significant differences observed. However, Eap1 released 
the antioxidant peptides in a shorter time than the com-
binations. Figure 7 shows the ferric reducing capacity of 
peptides released at different hydrolysis time, Eap1-released 
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Figure 5: Peptides released from the whey protein concentrate by enzy-
matic hydrolysis with individual enzymes (◆ Eap1,  chymotrypsin and ▲ 
trypsin) and with enzymatic cocktail (× Chymotrypsin-Eap1,＊ Tryp-
sin-Eap1, ● Chymotrypsin-Trypsin and ︱Chymotrypsin-Eap1-Trypsin).
Figura 5: Péptidos liberados del concentrado proteico del suero lácteo 
empleando las enzimas individuales (◆ Eap1,  Quimotripsina ▲ Tripsina) 
y las combinaciones enzimáticas (× Quimotripsina-Eap1,＊ Tripsina-Eap1, ● 
Quimotripsina-Tripsina y︱Quimotripsina-Eap1-Tripsina).
Figure 6: Antioxidant activity of peptides released from the whey protein 
concentrate by enzymatic hydrolysis with individual enzymes (◆ Eap1, 
 chymotrypsin and ▲ trypsin) and with enzymatic cocktail (× Chymo-
trypsin-Eap1,＊ Trypsin-Eap1, ● Chymotrypsin-Trypsin and ︱Chymotryp-
sin-Eap1-Trypsin).
Figura 6: Actividad antioxidante de los péptidos liberados del concentrado 
proteico del suero lácteo empleando las enzimas individuales (◆ Eap1, 
 Quimotripsina ▲ Tripsina) y las combinaciones enzimáticas (× Quimo-
tripsina-Eap1,＊ Tripsina-Eap1, ● Quimotripsina-Tripsina y︱Quimotripsi-
na-Eap1-Tripsina).
peptides present better ferric reducing capacity (835.20 
± 12 FeSO4 mM/100g WCP) in comparison with enzymes C 
(305.35 ± 7.1 FeSO4 mM/100g WCP) and T (205.82 ± 3.2 FeSO4 
mM/100 WCP) and enzymatic combinations (Chymotryp-
sin-Eap1 [399.09 ± 5.3 FeSO4 mM/100g WCP], Trypsin-Eap1 
[220.63 ± 2.8 FeSO4 mM/100g WCP], Chymotrypsin-Trypsin 
and Chymotrypsin-Eap1-Trypsin [23.3 ± 1.5 FeSO4 mM/100g 
WCP]). The statistical analysis showed significant differences 
(p<0.05, R2 adjusted: 0.9307; R
2 adjusted: 0.9543) in hydrolysis times 
depending on the enzymatic mixture.
Antihypertensive activity peptides released by the action 
of the enzymatic combination
Figure 8 shows the percentage inhibition of ACE 
with respect to hydrolysis time. The enzymatic combination 
releases peptides with better antihypertensive activity after 
hydrolysis for 120 min (96 % ACE inhibition). Similarly, the 
peptides obtained with enzymes Eap1, C, and the enzymatic 
combination Eap1-C presented no significant differences; 
however, Eap1 released these peptides in less time. The sta-
tistical analysis revealed that hydrolysis time depends on the 
enzymatic combination used (p <0.05, R2 adjusted: 0.9991).
Figure 7: Ferric reducing activity of peptides released from the whey pro-
tein concentrate by enzymatic hydrolysis with individual enzymes (◆ Eap1, 
 chymotrypsin and ▲ trypsin) and with enzymatic cocktail (× Chymo-
trypsin-Eap1,＊ Trypsin-Eap1, ● Chymotrypsin-Trypsin and ︱ Chymotryp-
sin-Eap1-Trypsin).
Figura 7: Potencial reductor férrico de los péptidos liberados del concen-
trado proteíco del suero lácteo por medio de hidrólisis enzimática con 
las enzimas individuales (◆ Eap1,  quimotripsina y ▲ tripsina) y con el 
cóctel enzimático (× Quimotripsina-Eap1,＊ Tripsina-Eap1, ● Quimotripsina 
-Tripsina y ︱Quimotripsina-Eap1-Tripsina).
Figure 8: ACE inhibition percentage of peptides released from the whey 
protein concentrate by enzymatic hydrolysis with individual enzymes (◆ 
Eap1,  chymotrypsin and ▲ trypsin) and with enzymatic cocktail (× Chy-
motrypsin-Eap1, ＊ Trypsin-Eap1, ● Chymotrypsin-Trypsin and ︱Chymo-
trypsin-Eap1-Trypsin).
Figura 8: Actividad antihipertensiva de los péptidos liberados del con-
centrado proteico del suero lácteo empleando las enzimas individuales 
(◆ Eap1,  Quimotripsina ▲ Tripsina) y las combinaciones enzimáticas (× 
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The peptides obtained with the different enzymatic 
combinations, suggest their possible uses in the elaboration 
of protein hydrolysates for applications requiring higher 
degrees of protein hydrolysis, than what is possible using 
individual enzymes (Figure 5). This experimental evidence 
can be interpreted starting from the fact that proteolytic en-
zymes act only on peptide bonds containing certain amino 
acids, for this reason, more substantial hydrolysis is obtained 
when using enzyme mixtures to maximize hydrolytic action. 
Our results differ from those reported by Ubalde and Cantera 
(2002), who used a mixture of Bacillus subtilis protease and 
obtain whey hydrolysates presenting a low degree of hydro-
lysis; however, the authors failed to determine the biological 
activity of such hydrolysates. Nevertheless, the results of our 
study coincide with those reported by Morris-Quevedo et al. 
(2001), who evaluated the effect of the use of five enzymatic 
combinations (bromelain-trypsin, bromelain-pancreatin, 
papain-bromelain, papain-trypsin, and pancreatin-papain) 
in obtaining protein hydrolysates from the biomass of the 
microalgae Chlorella vulgaris previously treated with ethanol; 
the best results were obtained with the papain-trypsin and 
papain-pancreatin mixtures. They also state that the use of 
enzymatic mixtures has a positive effect on the production 
of hydrolysates presenting a high degree of hydrolysis in 
comparison with individual enzymes, as shown by the com-
parison of their hydrolytic actions.
In general, the antioxidant and antihypertensive 
biological activity results obtained by the hydrolysis of milk 
serum proteins using individual enzymes (Eap1, C, and T) and 
enzymatic combinations (Eap1-C, Eap1-T, T-C, and C- Eap1-
T) show that the best results are obtained when using Eap1 
enzyme individually.
CONCLUSIONS
The aspartyl protease obtained from S. reilianum 
(Eap1) allows for the obtention of peptides with better 
antioxidant activity and similar antihypertensive activity in 
comparison with those obtained using commercial enzymes 
trypsin and chymotrypsin at 1.37 mUA/mL under these study 
conditions.
The peptides obtained using the enzymatic combi-
nations evaluated suggest that their hydrolysates present 
a higher degree of hydrolysis in comparison with those of 
individual enzymes.
These findings are interesting because obtaining active 
peptides by hydrolysis using proteases of fungal origin offers 
an important biotechnological alternative for the use of an 
agroindustrial by-product like whey, since Eap1 allows obten-
tion bioactive peptides in less time and with less enzymatic 
quantity.
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